Orion Laboratories Pty

Company snapshot

We provide our patients with flexible hours, affordable prices, and accept all types of insurance, including Medicaid. When healthcare providers have access to fast and accurate diagnostic information, they can deliver the best possible care to their patients, with a more personalized and efficient approach. Our services help providers achieve this goal and ensure that patients receive the highest

• 4 approved product(s) across US/EU regulatory metadata.
• 9 active pipeline program(s) linked via ClinicalTrials.gov.
• 9 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Orion Laboratories Pty. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Orion Laboratories Pty.

1. Jun 8, 2026 Clinical update

   3135004 — Phase 1

2. Jun 8, 2026 Clinical update

   3135003 — Phase 1

3. Jun 8, 2026 Clinical update

   3137001 — Phase 1

4. Jun 8, 2026 Clinical update

   3134003 — Phase 2

5. Jun 8, 2026 Clinical update

   3133004 — Phase 2

View all clinical trial activity →

• What is Orion Laboratories Pty?

  Orion Laboratories is a pharma organization headquartered in Baton Rouge, USA. Primary therapeutic focus areas include Metastatic castration-resistant prostate cancer., short-term treatment of insomnia, Parkinson desease, Hearing Loss, Chronic Pain due to Ostheoarthritis of the k

• Is Orion Laboratories Pty publicly traded?

  Orion Laboratories Pty appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Orion Laboratories Pty develop or market?

  We link 20 drug profile(s) where Orion Laboratories Pty is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/orion#company-drugs.

• What are the latest developments for Orion Laboratories Pty?

  In the last 12 months our linked public records show 9 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Orion Laboratories Pty focus on?

  Orion Laboratories Pty focuses on Metastatic castration-resistant prostate cancer., short-term treatment of insomnia, Parkinson desease based on our analysis of their pipeline programs and drug development activities.